317 related articles for article (PubMed ID: 28151871)
1. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.
Shafi T; Sozio SM; Luly J; Bandeen-Roche KJ; St Peter WL; Ephraim PL; McDermott A; Herzog CA; Crews DC; Scialla JJ; Tangri N; Miskulin DC; Michels WM; Jaar BG; Zager PG; Meyer KB; Wu AW; Boulware LE;
Medicine (Baltimore); 2017 Feb; 96(5):e5924. PubMed ID: 28151871
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Characteristics and Antihypertensive Medications for Mortality of Elderly Hospitalized Hemodialysis patients: a Multicenter Retrospective Study in China.
Song YH; Cai GY; Xiao YF; Liu JQ; Chen XM
Saudi J Kidney Dis Transpl; 2021; 32(3):637-644. PubMed ID: 35102905
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis.
Chang TI; Zheng Y; Montez-Rath ME; Winkelmayer WC
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1401-1412. PubMed ID: 27354656
[TBL] [Abstract][Full Text] [Related]
5. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.
Shireman TI; Mahnken JD; Phadnis MA; Ellerbeck EF
BMC Cardiovasc Disord; 2016 Mar; 16():60. PubMed ID: 27012911
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study.
Foley RN; Herzog CA; Collins AJ;
Kidney Int; 2002 Nov; 62(5):1784-90. PubMed ID: 12371980
[TBL] [Abstract][Full Text] [Related]
8. Combination antihypertensive therapy among patients with COPD.
Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
[TBL] [Abstract][Full Text] [Related]
9. DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
Karaboyas A; Xu H; Morgenstern H; Locatelli F; Jadoul M; Nitta K; Dasgupta I; Tentori F; Port FK; Robinson BM
Kidney Int; 2018 Sep; 94(3):589-598. PubMed ID: 29908836
[TBL] [Abstract][Full Text] [Related]
10. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
Smith SM; Winterstein AG; Gurka MJ; Walsh MG; Keshwani S; Libby AM; Hogan WR; Pepine CJ; Cooper-DeHoff RM
J Am Heart Assoc; 2023 Jan; 12(1):e026652. PubMed ID: 36565195
[TBL] [Abstract][Full Text] [Related]
11. Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.
Chan KE; Ikizler TA; Gamboa JL; Yu C; Hakim RM; Brown NJ
Kidney Int; 2011 Nov; 80(9):978-985. PubMed ID: 21775975
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
13. Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients.
Wetmore JB; Mahnken JD; Mukhopadhyay P; Hou Q; Ellerbeck EF; Rigler SK; Spertus JA; Shireman TI
Am J Kidney Dis; 2011 Jul; 58(1):73-83. PubMed ID: 21621889
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive medication exposure and cardiovascular outcomes in hemodialysis patients.
Shireman TI; Phadnis MA; Wetmore JB; Zhou X; Rigler SK; Spertus JA; Ellerbeck EF; Mahnken JD
Am J Nephrol; 2014; 40(2):113-22. PubMed ID: 25139551
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.
Tangri N; Miskulin DC; Zhou J; Bandeen-Roche K; Michels WM; Ephraim PL; McDermott A; Crews DC; Scialla JJ; Sozio SM; Shafi T; Jaar BG; Meyer K; Boulware LE;
Nephrol Dial Transplant; 2015 Apr; 30(4):667-75. PubMed ID: 25366328
[TBL] [Abstract][Full Text] [Related]
16. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
[TBL] [Abstract][Full Text] [Related]
17. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Patterns in Antihypertensive Drugs Medication and Mortality in Incident Dialysis Patients: A Multicenter Prospective Cohort Study.
Fujii M; Inaguma D; Koide S; Ito E; Takahashi K; Hayashi H; Tsuboi N; Hasegawa M; Yuzawa Y
Ther Apher Dial; 2019 Aug; 23(4):353-361. PubMed ID: 30565866
[TBL] [Abstract][Full Text] [Related]
19. Risks associated with continuation of potentially inappropriate antihypertensive medications in older adults receiving hemodialysis.
Hall RK; Morton S; Wilson J; Ephraim PL; Boulware LE; St Peter WL; Colón-Emeric C; Pendergast J; Scialla JJ
BMC Nephrol; 2021 Jun; 22(1):232. PubMed ID: 34147085
[TBL] [Abstract][Full Text] [Related]
20. Strategies and feasibility of hypertension control in a prevalent hemodialysis cohort.
Agarwal R
Clin Nephrol; 2000 May; 53(5):344-53. PubMed ID: 11305807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
